Its importance in arthritis progression was illustrated by the observation that in the K/BxN STA model, both GM-CSF KO mice and WT mice treated with anti-GM-CSF mAb showed less severe arthritis but with a similar time of onset compared to WT control mice (43). Here, CSF2 is linked to arthritic joint disease.